Valuation: Tristel plc

Market Cap 196M 261M 234M 216M 366M 24.76B 371M 2.59B 1.03B 12.98B 979M 958M 41.16B P/E 2026
24.1x
P/E 2027 * 22.3x
Enterprise Value 186M 248M 223M 205M 348M 23.55B 353M 2.46B 978M 12.34B 931M 911M 39.14B EV / Sales 2026
3.44x
EV / Sales 2027 * 3.24x
Free-Float
93.07%
Yield 2026
3.73%
Yield 2027 * 3.85%
1 day+1.84%
1 week+6.41%
Current month+1.22%
1 month+1.47%
3 months-1.19%
6 months+11.41%
Current year-0.60%
1 week 385
Extreme 385
415
1 month 385
Extreme 385
445
Current year 350
Extreme 350
450
1 year 350
Extreme 350
450
3 years 260
Extreme 260
510
5 years 260
Extreme 260
510
10 years 143.94
Extreme 143.94
680
Manager TitleAgeSince
Chief Executive Officer 64 01/08/2026
Director of Finance/CFO - 01/01/2025
Chief Executive Officer - 30/06/2026
Director TitleAgeSince
Director/Board Member 54 19/10/2017
Chairman 65 17/12/2019
Director/Board Member 68 27/04/2020
Date Insider Type Main position Quantity % Market Cap. Importance
23/3/26 Buy

Director

2,597 0.0054%
3/3/26 Buy

Director

770 0.0016%
3/3/26 Buy

Director

1,540 0.0032%
Change 5-day change 1-year change 3-year change Capi.($)
+1.84%+6.41%+13.70%+3.75% 261M
-1.70%+0.63%-18.93%+11.04% 178B
-1.54%-0.98%-21.45%+15.09% 116B
-0.89%-0.72%-0.19%+35.32% 115B
-0.80%+3.71%-43.23%+7.11% 93.1B
-1.40%-5.21%-3.18%+73.40% 62.09B
+0.17%-0.34%+10.87%+84.40% 55.87B
-0.69%+0.63%+4.27%-22.48% 53.12B
-1.57%+0.60%-13.31%+43.41% 44.22B
-0.83%+2.11%-3.97%-9.59% 33.59B
Average -0.47%+2.26%-7.54%+24.14% 75.13B
Weighted average by Cap. -0.50%+2.37%-13.29%+24.11%

Financials

2026 2027 *
Net sales 51.18M 68.1M 61.12M 56.44M 95.65M 6.47B 96.83M 677M 269M 3.39B 256M 250M 10.75B 56.11M 74.67M 67.02M 61.88M 105M 7.09B 106M 742M 295M 3.72B 280M 274M 11.79B
Net income 7.93M 10.56M 9.47M 8.75M 14.83M 1B 15.01M 105M 41.65M 526M 39.62M 38.78M 1.67B 8.85M 11.77M 10.57M 9.76M 16.54M 1.12B 16.74M 117M 46.46M 586M 44.19M 43.25M 1.86B
Net Debt -9.59M -12.76M -11.45M -10.57M -17.92M -1.21B -18.14M -127M -50.33M -635M -47.88M -46.86M -2.01B -14.27M -18.98M -17.04M -15.73M -26.67M -1.8B -26.99M -189M -74.91M -945M -71.26M -69.74M -3B
Projected Income Statement - Annual - Tristel plc
Logo Tristel plc
Tristel plc is a United Kingdom-based infection prevention company. The Company's core business is the sale to hospitals of its chlorine dioxide chemistry used for the decontamination of medical devices under the Tristel brand, and for the sporicidal disinfection of environmental surfaces under the Cache brand. The Company operates through three segments: Hospital medical device decontamination, Hospital environmental surface disinfection and others. It manufactures and sells medical device decontamination products which are used primarily for infection control in hospitals. The Company also manufactures and sells hospital environmental surface disinfection products. It addresses pharmaceutical and personal care product manufacturing industries, veterinary and animal welfare sectors. The Tristel brand offers airway management, cardiology, ear, nose and throat, endoscopy, gastrointestinal (GI) physiology, laboratory, ophthalmology, and ultrasound.
Employees
282
Date Price Change Volume
28/10/26 GBX 415.00 +1.84% 8,838
27/10/26 GBX 407.50 0.00% 233,675
26/10/26 GBX 407.50 +1.24% 93,402
23/10/26 GBX 402.50 +3.21% 264,921
22/10/26 GBX 390.00 0.00% 116,313
Trader
Investor
Global
Quality
ESG MSCI
AAA
MarketScreener Ratings - Tristel plc
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
4.075GBP
Average target price
4.707GBP
Spread / Average Target
+15.50%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Tristel plc
  1. Stock Market
  2. Stocks
  3. TSTL Stock